ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Anthrax Vaccines Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3A7414
Home | Market Reports | Health| Pharmacy
Global Veterinary Anthrax Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Veterinary Anthrax Vaccines Market Research Report 2025

Code: QYRE-Auto-3A7414
Report
August 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac
JOVAC

Veterinary Anthrax Vaccines Market Size

The global market for Veterinary Anthrax Vaccines was valued at US$ 38 million in the year 2024 and is projected to reach a revised size of US$ 63.1 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Veterinary Anthrax Vaccines Market

Veterinary Anthrax Vaccines Market

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 104%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Anthrax Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Anthrax Vaccines.
The Veterinary Anthrax Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Anthrax Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Anthrax Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Anthrax Vaccines Market Report

Report Metric Details
Report Name Veterinary Anthrax Vaccines Market
Accounted market size in year US$ 38 million
Forecasted market size in 2031 US$ 63.1 million
CAGR 7.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Cow
  • Sheep
  • Swine
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company, Empresa Colombiana de Productos Veterinarios S.A, Indian Immunologicals Limited, Institute for Biological Products, Intervac (PVT) Ltd, JOVAC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Anthrax Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Anthrax Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary Anthrax Vaccines Market growing?

Ans: The Veterinary Anthrax Vaccines Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Veterinary Anthrax Vaccines Market size in 2031?

Ans: The Veterinary Anthrax Vaccines Market size in 2031 will be US$ 63.1 million.

What is the Veterinary Anthrax Vaccines Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Veterinary Anthrax Vaccines Market report?

Ans: The main players in the Veterinary Anthrax Vaccines Market are Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company, Empresa Colombiana de Productos Veterinarios S.A, Indian Immunologicals Limited, Institute for Biological Products, Intervac (PVT) Ltd, JOVAC

What are the Application segmentation covered in the Veterinary Anthrax Vaccines Market report?

Ans: The Applications covered in the Veterinary Anthrax Vaccines Market report are Cow, Sheep, Swine, Other

What are the Type segmentation covered in the Veterinary Anthrax Vaccines Market report?

Ans: The Types covered in the Veterinary Anthrax Vaccines Market report are Cell Free PA Vaccines, Live Vaccines

Recommended Reports

Veterinary Vaccines

Pet Health Drugs

Pet Nutrition Supplies

1 Veterinary Anthrax Vaccines Market Overview
1.1 Product Definition
1.2 Veterinary Anthrax Vaccines by Type
1.2.1 Global Veterinary Anthrax Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cell Free PA Vaccines
1.2.3 Live Vaccines
1.3 Veterinary Anthrax Vaccines by Application
1.3.1 Global Veterinary Anthrax Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Cow
1.3.3 Sheep
1.3.4 Swine
1.3.5 Other
1.4 Global Veterinary Anthrax Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Anthrax Vaccines Revenue 2020-2031
1.4.2 Global Veterinary Anthrax Vaccines Sales 2020-2031
1.4.3 Global Veterinary Anthrax Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Anthrax Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Anthrax Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Anthrax Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Anthrax Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Anthrax Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Anthrax Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Anthrax Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Anthrax Vaccines, Date of Enter into This Industry
2.8 Global Veterinary Anthrax Vaccines Market Competitive Situation and Trends
2.8.1 Global Veterinary Anthrax Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Anthrax Vaccines Players Market Share by Revenue
2.8.3 Global Veterinary Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Anthrax Vaccines Market Scenario by Region
3.1 Global Veterinary Anthrax Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Anthrax Vaccines Sales by Region: 2020-2031
3.2.1 Global Veterinary Anthrax Vaccines Sales by Region: 2020-2025
3.2.2 Global Veterinary Anthrax Vaccines Sales by Region: 2026-2031
3.3 Global Veterinary Anthrax Vaccines Revenue by Region: 2020-2031
3.3.1 Global Veterinary Anthrax Vaccines Revenue by Region: 2020-2025
3.3.2 Global Veterinary Anthrax Vaccines Revenue by Region: 2026-2031
3.4 North America Veterinary Anthrax Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Anthrax Vaccines Sales by Country (2020-2031)
3.4.3 North America Veterinary Anthrax Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Anthrax Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Anthrax Vaccines Sales by Country (2020-2031)
3.5.3 Europe Veterinary Anthrax Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Anthrax Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Anthrax Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Anthrax Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Anthrax Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Anthrax Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Anthrax Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Anthrax Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Anthrax Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Anthrax Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Anthrax Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Anthrax Vaccines Sales by Type (2020-2031)
4.1.1 Global Veterinary Anthrax Vaccines Sales by Type (2020-2025)
4.1.2 Global Veterinary Anthrax Vaccines Sales by Type (2026-2031)
4.1.3 Global Veterinary Anthrax Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Anthrax Vaccines Revenue by Type (2020-2031)
4.2.1 Global Veterinary Anthrax Vaccines Revenue by Type (2020-2025)
4.2.2 Global Veterinary Anthrax Vaccines Revenue by Type (2026-2031)
4.2.3 Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Anthrax Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Anthrax Vaccines Sales by Application (2020-2031)
5.1.1 Global Veterinary Anthrax Vaccines Sales by Application (2020-2025)
5.1.2 Global Veterinary Anthrax Vaccines Sales by Application (2026-2031)
5.1.3 Global Veterinary Anthrax Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Anthrax Vaccines Revenue by Application (2020-2031)
5.2.1 Global Veterinary Anthrax Vaccines Revenue by Application (2020-2025)
5.2.2 Global Veterinary Anthrax Vaccines Revenue by Application (2026-2031)
5.2.3 Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Anthrax Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Agrovet
6.1.1 Agrovet Company Information
6.1.2 Agrovet Description and Business Overview
6.1.3 Agrovet Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Agrovet Veterinary Anthrax Vaccines Product Portfolio
6.1.5 Agrovet Recent Developments/Updates
6.2 Bayer Sanidad Animal
6.2.1 Bayer Sanidad Animal Company Information
6.2.2 Bayer Sanidad Animal Description and Business Overview
6.2.3 Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Portfolio
6.2.5 Bayer Sanidad Animal Recent Developments/Updates
6.3 Biogenesis Bago SA
6.3.1 Biogenesis Bago SA Company Information
6.3.2 Biogenesis Bago SA Description and Business Overview
6.3.3 Biogenesis Bago SA Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biogenesis Bago SA Veterinary Anthrax Vaccines Product Portfolio
6.3.5 Biogenesis Bago SA Recent Developments/Updates
6.4 Botswana Vaccine Institute
6.4.1 Botswana Vaccine Institute Company Information
6.4.2 Botswana Vaccine Institute Description and Business Overview
6.4.3 Botswana Vaccine Institute Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Portfolio
6.4.5 Botswana Vaccine Institute Recent Developments/Updates
6.5 Central Veterinary Control and Research Institute
6.5.1 Central Veterinary Control and Research Institute Company Information
6.5.2 Central Veterinary Control and Research Institute Description and Business Overview
6.5.3 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Portfolio
6.5.5 Central Veterinary Control and Research Institute Recent Developments/Updates
6.6 Centro Diagnostico Veterinario
6.6.1 Centro Diagnostico Veterinario Company Information
6.6.2 Centro Diagnostico Veterinario Description and Business Overview
6.6.3 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Portfolio
6.6.5 Centro Diagnostico Veterinario Recent Developments/Updates
6.7 Ceva Sante Animale
6.7.1 Ceva Sante Animale Company Information
6.7.2 Ceva Sante Animale Description and Business Overview
6.7.3 Ceva Sante Animale Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Sante Animale Veterinary Anthrax Vaccines Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Colorado Serum Company
6.8.1 Colorado Serum Company Company Information
6.8.2 Colorado Serum Company Description and Business Overview
6.8.3 Colorado Serum Company Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Colorado Serum Company Veterinary Anthrax Vaccines Product Portfolio
6.8.5 Colorado Serum Company Recent Developments/Updates
6.9 Empresa Colombiana de Productos Veterinarios S.A
6.9.1 Empresa Colombiana de Productos Veterinarios S.A Company Information
6.9.2 Empresa Colombiana de Productos Veterinarios S.A Description and Business Overview
6.9.3 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Portfolio
6.9.5 Empresa Colombiana de Productos Veterinarios S.A Recent Developments/Updates
6.10 Indian Immunologicals Limited
6.10.1 Indian Immunologicals Limited Company Information
6.10.2 Indian Immunologicals Limited Description and Business Overview
6.10.3 Indian Immunologicals Limited Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Portfolio
6.10.5 Indian Immunologicals Limited Recent Developments/Updates
6.11 Institute for Biological Products
6.11.1 Institute for Biological Products Company Information
6.11.2 Institute for Biological Products Description and Business Overview
6.11.3 Institute for Biological Products Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Institute for Biological Products Veterinary Anthrax Vaccines Product Portfolio
6.11.5 Institute for Biological Products Recent Developments/Updates
6.12 Intervac (PVT) Ltd
6.12.1 Intervac (PVT) Ltd Company Information
6.12.2 Intervac (PVT) Ltd Description and Business Overview
6.12.3 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product Portfolio
6.12.5 Intervac (PVT) Ltd Recent Developments/Updates
6.13 JOVAC
6.13.1 JOVAC Company Information
6.13.2 JOVAC Description and Business Overview
6.13.3 JOVAC Veterinary Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 JOVAC Veterinary Anthrax Vaccines Product Portfolio
6.13.5 JOVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Anthrax Vaccines Industry Chain Analysis
7.2 Veterinary Anthrax Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Anthrax Vaccines Production Mode & Process Analysis
7.4 Veterinary Anthrax Vaccines Sales and Marketing
7.4.1 Veterinary Anthrax Vaccines Sales Channels
7.4.2 Veterinary Anthrax Vaccines Distributors
7.5 Veterinary Anthrax Vaccines Customer Analysis
8 Veterinary Anthrax Vaccines Market Dynamics
8.1 Veterinary Anthrax Vaccines Industry Trends
8.2 Veterinary Anthrax Vaccines Market Drivers
8.3 Veterinary Anthrax Vaccines Market Challenges
8.4 Veterinary Anthrax Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac
JOVAC
List of Tables
 Table 1. Global Veterinary Anthrax Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Anthrax Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Anthrax Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Anthrax Vaccines Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Anthrax Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Anthrax Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Anthrax Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Anthrax Vaccines Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Anthrax Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Anthrax Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Anthrax Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Anthrax Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Anthrax Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Anthrax Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Anthrax Vaccines Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Veterinary Anthrax Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Anthrax Vaccines Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Veterinary Anthrax Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Anthrax Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Anthrax Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Anthrax Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Anthrax Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Anthrax Vaccines Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Veterinary Anthrax Vaccines Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Veterinary Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Anthrax Vaccines Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Veterinary Anthrax Vaccines Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Veterinary Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Anthrax Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Anthrax Vaccines Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Veterinary Anthrax Vaccines Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Veterinary Anthrax Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Anthrax Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Anthrax Vaccines Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Veterinary Anthrax Vaccines Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Veterinary Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Anthrax Vaccines Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Veterinary Anthrax Vaccines Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Veterinary Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Anthrax Vaccines Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Veterinary Anthrax Vaccines Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Veterinary Anthrax Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Anthrax Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Anthrax Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Anthrax Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Anthrax Vaccines Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Veterinary Anthrax Vaccines Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Veterinary Anthrax Vaccines Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Veterinary Anthrax Vaccines Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Veterinary Anthrax Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Anthrax Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Anthrax Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Anthrax Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Anthrax Vaccines Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Veterinary Anthrax Vaccines Price (USD/Pcs) by Application (2026-2031)
 Table 70. Agrovet Company Information
 Table 71. Agrovet Description and Business Overview
 Table 72. Agrovet Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Agrovet Veterinary Anthrax Vaccines Product
 Table 74. Agrovet Recent Developments/Updates
 Table 75. Bayer Sanidad Animal Company Information
 Table 76. Bayer Sanidad Animal Description and Business Overview
 Table 77. Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Bayer Sanidad Animal Veterinary Anthrax Vaccines Product
 Table 79. Bayer Sanidad Animal Recent Developments/Updates
 Table 80. Biogenesis Bago SA Company Information
 Table 81. Biogenesis Bago SA Description and Business Overview
 Table 82. Biogenesis Bago SA Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Biogenesis Bago SA Veterinary Anthrax Vaccines Product
 Table 84. Biogenesis Bago SA Recent Developments/Updates
 Table 85. Botswana Vaccine Institute Company Information
 Table 86. Botswana Vaccine Institute Description and Business Overview
 Table 87. Botswana Vaccine Institute Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Botswana Vaccine Institute Veterinary Anthrax Vaccines Product
 Table 89. Botswana Vaccine Institute Recent Developments/Updates
 Table 90. Central Veterinary Control and Research Institute Company Information
 Table 91. Central Veterinary Control and Research Institute Description and Business Overview
 Table 92. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product
 Table 94. Central Veterinary Control and Research Institute Recent Developments/Updates
 Table 95. Centro Diagnostico Veterinario Company Information
 Table 96. Centro Diagnostico Veterinario Description and Business Overview
 Table 97. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product
 Table 99. Centro Diagnostico Veterinario Recent Developments/Updates
 Table 100. Ceva Sante Animale Company Information
 Table 101. Ceva Sante Animale Description and Business Overview
 Table 102. Ceva Sante Animale Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Ceva Sante Animale Veterinary Anthrax Vaccines Product
 Table 104. Ceva Sante Animale Recent Developments/Updates
 Table 105. Colorado Serum Company Company Information
 Table 106. Colorado Serum Company Description and Business Overview
 Table 107. Colorado Serum Company Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Colorado Serum Company Veterinary Anthrax Vaccines Product
 Table 109. Colorado Serum Company Recent Developments/Updates
 Table 110. Empresa Colombiana de Productos Veterinarios S.A Company Information
 Table 111. Empresa Colombiana de Productos Veterinarios S.A Description and Business Overview
 Table 112. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product
 Table 114. Empresa Colombiana de Productos Veterinarios S.A Recent Developments/Updates
 Table 115. Indian Immunologicals Limited Company Information
 Table 116. Indian Immunologicals Limited Description and Business Overview
 Table 117. Indian Immunologicals Limited Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Indian Immunologicals Limited Veterinary Anthrax Vaccines Product
 Table 119. Indian Immunologicals Limited Recent Developments/Updates
 Table 120. Institute for Biological Products Company Information
 Table 121. Institute for Biological Products Description and Business Overview
 Table 122. Institute for Biological Products Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Institute for Biological Products Veterinary Anthrax Vaccines Product
 Table 124. Institute for Biological Products Recent Developments/Updates
 Table 125. Intervac (PVT) Ltd Company Information
 Table 126. Intervac (PVT) Ltd Description and Business Overview
 Table 127. Intervac (PVT) Ltd Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product
 Table 129. Intervac (PVT) Ltd Recent Developments/Updates
 Table 130. JOVAC Company Information
 Table 131. JOVAC Description and Business Overview
 Table 132. JOVAC Veterinary Anthrax Vaccines Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. JOVAC Veterinary Anthrax Vaccines Product
 Table 134. JOVAC Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Veterinary Anthrax Vaccines Distributors List
 Table 138. Veterinary Anthrax Vaccines Customers List
 Table 139. Veterinary Anthrax Vaccines Market Trends
 Table 140. Veterinary Anthrax Vaccines Market Drivers
 Table 141. Veterinary Anthrax Vaccines Market Challenges
 Table 142. Veterinary Anthrax Vaccines Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Anthrax Vaccines
 Figure 2. Global Veterinary Anthrax Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Anthrax Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Cell Free PA Vaccines Product Picture
 Figure 5. Live Vaccines Product Picture
 Figure 6. Global Veterinary Anthrax Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Veterinary Anthrax Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Cow
 Figure 9. Sheep
 Figure 10. Swine
 Figure 11. Other
 Figure 12. Global Veterinary Anthrax Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Veterinary Anthrax Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Veterinary Anthrax Vaccines Sales (2020-2031) & (K Pcs)
 Figure 15. Global Veterinary Anthrax Vaccines Average Price (USD/Pcs) & (2020-2031)
 Figure 16. Veterinary Anthrax Vaccines Report Years Considered
 Figure 17. Veterinary Anthrax Vaccines Sales Share by Manufacturers in 2024
 Figure 18. Global Veterinary Anthrax Vaccines Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Veterinary Anthrax Vaccines Players: Market Share by Revenue in Veterinary Anthrax Vaccines in 2024
 Figure 20. Veterinary Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Veterinary Anthrax Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Veterinary Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 23. North America Veterinary Anthrax Vaccines Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Veterinary Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 27. Europe Veterinary Anthrax Vaccines Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Veterinary Anthrax Vaccines Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Veterinary Anthrax Vaccines Revenue Market Share by Region (2020-2031)
 Figure 35. China Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Veterinary Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Veterinary Anthrax Vaccines Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Veterinary Anthrax Vaccines Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Veterinary Anthrax Vaccines Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Veterinary Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Veterinary Anthrax Vaccines by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Veterinary Anthrax Vaccines by Type (2020-2031)
 Figure 56. Global Veterinary Anthrax Vaccines Price (USD/Pcs) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Veterinary Anthrax Vaccines by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Veterinary Anthrax Vaccines by Application (2020-2031)
 Figure 59. Global Veterinary Anthrax Vaccines Price (USD/Pcs) by Application (2020-2031)
 Figure 60. Veterinary Anthrax Vaccines Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Anthrax Vaccines Market Insights Forecast to 2030
Biothrax Anthrax Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anthrax Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Vaccines Market Insights Forecast to 2030
Cattle and Sheep Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines for Livestock Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ruminant Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Companion Animals Rabies Veterinary Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Anti Rabies Vaccine Market Research Report 2024
Global Brucellosis Vaccines Market Research Report 2025
Animal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Clostridium Vaccines Market Research Report 2025
Veterinary Vaccine Market
Global Livestock Animal Vaccination Market Research Report 2025
Global Livestock Animal Vaccines Market Research Report 2024
Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Rabies Vaccine Vero Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Abthrax Market Insights Forecast to 2030
Global Leptospirosis Vaccine Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions